Martin Joyce
Director/Board Member at ALDEYRA THERAPEUTICS, INC.
Net worth: 78 372 $ as of 2024-03-30
Profile
Martin Joseph Joyce is an Independent Director at Aldeyra Therapeutics, Inc. and a Director at Helio Vision, Inc. He was previously the Chief Financial Officer & Executive Vice President at BioSphere Medical, Inc. and the Chief Financial Officer at Hepregen Corp., Lucid Holdings LLC, and Caliber Imaging & Diagnostics, Inc. He was also the Chief Financial Officer-North America at EMD Serono, Inc. and the Managing Partner at Stratex Group LLC.
Joyce holds an MBA from Suffolk University and an undergraduate degree from Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 23,967 ( 0.04% ) | 78 372 $ | 2024-03-30 |
Martin Joyce active positions
| Companies | Position | Start |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Director/Board Member | 2013-09-30 |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Director/Board Member | - |
Former positions of Martin Joyce
| Companies | Position | End |
|---|---|---|
| CALIBER IMAGING & DIAGNOSTICS, INC. | Director of Finance/CFO | 2012-07-08 |
Lucid Holdings LLC
 Lucid Holdings LLC Packaged SoftwareTechnology Services Lucid Holdings LLC is a holding company which engages in the provision of market research technology services. It offers sample buyers of all shapes and sizes simplified access to programmatic sample. The company was founded by Patrick Comer in 2010 and is headquartered in New Orleans, LA. | Director of Finance/CFO | 2012-06-30 |
BioSphere Medical, Inc.
 BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Director of Finance/CFO | 2010-08-31 |
| Stratex Group LLC | Corporate Officer/Principal | 2004-08-31 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 2000-12-31 |
Training of Martin Joyce
| Suffolk University | Masters Business Admin |
| Northeastern University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALDEYRA THERAPEUTICS, INC. | Health Technology |
| CALIBER IMAGING & DIAGNOSTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
Hepregen Corp.
 Hepregen Corp. Pharmaceuticals: MajorHealth Technology Hepregen Corp. develops bioengineering solutions for drug development. Its products include human HepatoPac and HepatoMune, rat, monkey, dog and multi species HepatoPac. The company was founded by Bernadette C. Fendrock, Sangeeta N. Bhatia and Salman Khetani in 2007 and is headquartered in Medford, MA. | Health Technology |
Lucid Holdings LLC
Lucid Holdings LLC Packaged SoftwareTechnology Services Lucid Holdings LLC is a holding company which engages in the provision of market research technology services. It offers sample buyers of all shapes and sizes simplified access to programmatic sample. The company was founded by Patrick Comer in 2010 and is headquartered in New Orleans, LA. | Technology Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Stratex Group LLC | |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Martin Joyce
